Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France

Starting soon

Conditions studied: HIV - Human Immunodeficiency Virus, Socio-economic Status, Migrants

In brief

Migrants living with HIV - whether the infection was diagnosed in their country of origin or in France- frequently experience vulnerabilities related to their migration trajectories and often face socioeconomic and administrative instability upon arrival . The primary outcome of this study is to compare the immunovirological efficacy of antiretroviral therapy among migrants living with HIV patients according to their social and administrative status.

Key facts

Study ID

NCT07691424

Run by

University Hospital, Clermont-Ferrand

People needed

150

Starts

2026-07-15

Expected to finish

2030-02-15

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (≥18 years of age);
• Migrant patients (i.e., individuals who entered France for the first time from another country) receiving care at Clermont-Ferrand University Hospital between January 1, 2010, and December 31, 2022, whose HIV infection was either known at the time of their arrival in France or diagnosed within 12 months after their arrival in France.
• Non-inclusion Criteria:
• Patients who declined to participate in the study;
• Patients who do not speak French and for whom no interpretere was available
• Adults subject to a legal protection measure (i.e., under guardianship, curatorship, or judicial protection)

Where it is running

• Clermont-Ferrand University Hospital — Clermont-Ferrand, France, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.